Infantile Spasms Oral Solution

About Upsher-Smith

Upsher-Smith is a century-old, trusted U.S. pharmaceutical company operating as a commercial-stage entity with a hybrid portfolio of branded and generic drugs. Following its acquisition by Bora Pharmaceuticals in April 2024 and subsequent merger with TWi Pharmaceuticals, it has strengthened its pipeline and expanded its product offerings, particularly in neurology and rare diseases. The company's strategy focuses on strategic acquisitions, partnerships, and a commitment to reliable supply to serve patients with cost-effective therapies.

Therapeutic Areas